SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, cilt.71, sa.4, ss.340-343, 2011 (SCI-Expanded)
We aimed to investigate the relationship between serum osteoprotegerin (OPG) level and glycemic control, lipids, renal function, microalbuminuria, insulin resistance and markers of atherosclerosis including C-reactive protein (CRP), fibrinogen and erythrocyte sedimentation rate (ESR) in patients with type 2 diabetes mellitus (DM). A total of 166 patients (99 women and 67 men) with type 2 DM were recruited in the study. Serum OPG level was higher in poorly controlled diabetic patients (HbA(1c) >= a parts per thousand yen 7%) than in well-controlled diabetic patients (HbA(1c) < 7%) [4.0 (3.6--5.0) and 3.5 (2.9--4.4) pmol/L, p == 0.02]. There was no difference between the patients with and without microalbuminuria with respect to OPG levels (p > 0.05). LogOPG was correlated with age (r == 0.47, p == 0.0001). After adjustment for age, sex and BMI, logOPG correlated positively with fasting blood glucose (FBG) (r == 0.28, p == 0.001), prandial blood glucose (PBG) (r == 0.22, p == 0.009), glycated hemoglobin (HbA(1c)) (r == 0.26, p == 0.002), logHOMA-IR (r == 0.30, p == 0.006), fibrinogen (r == 0.17, p == 0.04), mean albumin excretion rate (MAER) (r == 0.20, p == 0.01) and negatively with creatinine clearance (r == -- 0.20, p == 0.01). Regression analysis revealed that logOPG was independently associated with age (p == 0.0001), HbA(1c) (p == 0.01) and MAER (p == 0.02) (r